Colgate-Palmolive (CL): Analyst Notes Increasing Interest in Triclosan Following Negative Article

In a research note, Deutsche Bank analyst Bill Schmitz Jr discussed intense interest in triclosan, a chemical found in Colgate-Palmolive's (NYSE: CL) Total. Previously, news reports from Bloomberg linked the chemical triclosan to cancer-cell growth and disrupted development in animals (Link 1, Link 2). Triclosan was also compared to aspartame, given similarity in social and traditional media trends.

"While it is too early to tell if there will be an impact on product sales, a google trends analysis shows a relative spike in “Interest over time” (*see below) in triclosan (and Colgate triclosan) this month which seems to eclipse the spike in diet coke aspartame last year. Both triclosan and Colgate triclosan interest is at the maximum 100 level," he said.

Deutsche Bank has a Hold rating on Colgate-Palmolive Company with a price target of $70.

For an analyst ratings summary and ratings history on Colgate-Palmolive Company click here. For more ratings news on Colgate-Palmolive Company click here.

Shares of Colgate-Palmolive Company closed at $64.13 yesterday.

You May Also Be Interested In

• Compass Minerals International (CMP) PT Lowered to $15 at Deutsche Bank
• Summit Insights Downgrades Silicon Labs (SLAB) to Hold, 'expect its stock to be an inline performer'
• Boston Scientific (BSX) PT Raised to $80 at BTIG